Top Image Analysis Solution Companies
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

Flagship Biosciences: Accelerating Drug Development

Top 10 Image Analysis Solution Companies - 2020

The pharmaceutical industry is at an exciting time when it comes to digital pathology and image analysis. One of the recent advancements in image analysis is Chemical Imaging (CI). It brings together conventional imaging and spectroscopy to gain both spatial and spectral information necessary in the characterization of biomolecules. In the light of these discoveries and the current trend of digitalization, it seems that every part of the drug development and manufacturing process is moving toward automation, improving processing speeds and information accuracy.

Moreover, as pharmaceutical companies are freeing up their pathologists’ and pharmacists’ time to focus on finding new treatments for the COVID-19 pandemic, many of the mundane tasks like image visualization are now being automated. And, with the advancement of computer vision and artificial intelligence, the domain of image analysis is witnessing an influx of diversified opportunities. AI applications for image analysis use deep learning algorithms and analytics to systematically assess images for tumors or suspicious lesions and to provide detailed reports on their findings instantly.

Additionally, pathology laboratories are now using these digitally-enabled image analysis tools for in-vitro diagnostics. This is a huge step forward and a step that will benefit not only laboratories and patients but also the pharmaceutical and diagnostic industry as it will enable more widespread use of quantitative measures that have been limited to high-end discovery and research facilities.

At this juncture, there is a wide variety of image analysis solutions providers entering the industry with a set of advanced and insightful offerings. To help companies strengthen their content infrastructure and simultaneously enable growth in the industry, Pharma Tech Outlook has compiled a list of the top 10 image analysis solution providers. The list comprises prominent organizations in the industry that solve image analysis challenges by implementing the current trends in the space. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for the aspiring CIOs.

We present to you Pharma Tech Outlook’s, “Top 10 Image Analysis Solution Providers – 2020.”

Top Image Analysis Solution Companies

Cellular Technology Limited (CTL), headquartered in Cleveland, OH, is a global biotechnology company with locations and distributors worldwide. We are the pioneer and industry leader in the development, use, and manufacture of standardized tools for specializing in cellular immune assays

www.immunospot.com

Flagship Biosciences is a technology-driven tissue analysis services company that offers sophisticated tissue image analysis solutions that give clients a distinct advantage in the drug development process

www.flagshipbio.com

Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation and consumable company that commercializes high-throughput biopharmaceutical formulation and quality control tools for particle analysis using state-of-the-art custom optics and image processing techniques. Halo Labs’ core mission has been to provide researchers with unprecedented insights into the particles present in their processes by leveraging our core scientific competency: optical imaging on membranes. Over the years, Halo Labs has been the recipient of many prestigious awards, and has received over $6M in research grants from agencies including DARPA, FDA, NSF, NIST and NIH. Today, we dedicate our collective experience and novel technology to empower formulation researchers to learn more about the stability and quality of their biological drugs faster and with more accuracy than ever before

halolabs.com

Quantified Biology comes into the picture with curated bio-image analysis software for the research and development units within pharmaceutical companies and academic research groups to help them overcome the research bottleneck and succeed in their image-based experimentation for drug discovery. The company’s solutions are entirely tractable and allow the researchers to understand what the algorithm does to the image data at each step. Besides, unlike machine learning models the solutions of Quantified Biology can also work with smaller or medium-sized data-sets, with more than 95percent agreement with manual analysis done by an expert

www.quantified-biology.com

Aiforia Technologies

Aiforia Technologies

Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology, and experienced life science entrepreneurs. The Aiforia® Platform brings together image-based AI and high-performance cloud computing, optimized in particular for enormous images in the field of digital pathology. Built on an intuitive user interface, it is the only one on the market where no local hardware or prior computing knowledge is needed to train and apply advanced deep learning models to analytical and diagnostic tasks

Akoya Biosciences

Akoya Biosciences

Akoya Biosciences, The Spatial Biology Company™, offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX® system is the only benchtop platform that can efficiently quantify more than 40 protein biomarkers and is ideally suited for biomarker discovery. The Phenoptics™ platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials

BioView

BioView

BioView develops, manufactures and markets innovative automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Operating since 2000, BioView is headquartered in Israel and has a fully owned subsidiary in the Unites States, which is responsible for sales and support in America. Products are also an internationally distributed by Abbott Molecular. Founded and managed by experts, BioView leverages its knowledge and extensive expertise in the areas of medical devices combined with clinical and research applications, in creating its breakthrough imaging and analysis solutions.Lead by senior executives with vast accumulated experience in both the development and successful marketing of solutions such as diagnostic equipment with vision applications, BioView remains one step ahead of the game with assay-specific applications ready for use even before the tests reach the market

Fluidigm Corporation

Fluidigm Corporation

Fluidigm is an innovative leader in the life science industry committed to improving the human condition. We hire team members who share this commitment, and, in turn, we strive to create an environment where you can do your best work. We are a values-driven organization. We believe strong shared values are essential for Fluidigm to evolve and grow and to be successful for the long term. They inform our relationships with customers, suppliers, investors and each other. They ensure that we model respect and inclusiveness in our words and actions Operating since 2000, BioView is headquartered in Israel and has a fully owned subsidiary in the Unites States, which is responsible for sales and support in America. Products are also an internationally distributed by Abbott Molecular. Founded and managed by experts, BioView leverages its knowledge and extensive expertise in the areas of medical devices combined with clinical and research applications, in creating its breakthrough imaging and analysis solutions.Lead by senior executives with vast accumulated experience in both the development and successful marketing of solutions such as diagnostic equipment with vision applications, BioView remains one step ahead of the game with assay-specific applications ready for use even before the tests reach the market

Leica Microsystems

Leica Microsystems

Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. Ever since the company started as a family business in the nineteenth century, its instruments have been widely recognized for their optical precision and innovative technology. It is one of the market leaders in compound and stereo microscopy, digital microscopy, confocal laser scanning microscopy with related imaging systems, electron microscopy sample preparation, and surgical microscopes Operating since 2000, BioView is headquartered in Israel and has a fully owned subsidiary in the Unites States, which is responsible for sales and support in America. Products are also an internationally distributed by Abbott Molecular. Founded and managed by experts, BioView leverages its knowledge and extensive expertise in the areas of medical devices combined with clinical and research applications, in creating its breakthrough imaging and analysis solutions.Lead by senior executives with vast accumulated experience in both the development and successful marketing of solutions such as diagnostic equipment with vision applications, BioView remains one step ahead of the game with assay-specific applications ready for use even before the tests reach the market

Life Image

Life Image

Life Image is a medical evidence and image exchange network providing access to points of care and curated imaging data. Founded in 2008, Life Image’s Interoperability Suite is a digital platform that uses vendor-agnostic integration standards to connect more than 10,000 facilities, 160,000 providers, 58,000 global clinics, and millions of patients with life sciences, medical devices, and telehealth companies. The Interoperability Suite is interconnected to a technical ecosystem of EHRs, PACS, AI solutions, cloud environments, and analytics platforms. Its industry-leading connectivity solutions include Provider Exchange, Patient Connect, Network Build, Network Access and RWD Curation. Life Image is the exclusive provider of Real World Imaging,™ large-scale, heterogeneous, de-identified imaging sets linkable to other longitudinal data